New Study Questions Effectiveness of Cipro: Severe Adverse Events

According to the study published in the April issue of the journal Antimicrobial Agents and Chemotherapy, E. coli bacteria's resistance to Cipro increased five-fold between 2000 and 2010. E. coli accounts for 75 percent to 95 percent of urinary tract infections. Cipro is a brand name for ciprofloxacin, of a class of antibiotic drugs known as fluoroquinolones, originally manufactured by Bayer …

Leave a Reply

Your email address will not be published.